Categories: News

ArisGlobal Signs EU AI Pact In Latest Commitment to Ethical AI Practices, Essential For Societal Benefits Including Enhanced Patient Safety

The EU AI Pact supports organizations in preparing for the EU AI Act, the world’s first comprehensive AI law. Joining the AI Pact reinforces ArisGlobal’s belief in a future underpinned by responsible AI.

BOSTON, Feb. 12, 2025 /PRNewswire/ — ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, today announced its official signing of the European Union’s AI Pact agreement. The public pledge promotes responsible and ethical AI development and deployment, underpinning AI’s “bigger picture”: its benefits to society.

The AI Pact is a voluntary framework created by the European Commission to help stakeholders prepare for the implementation of the EU AI Act. It is the first comprehensive regulation on AI by a major regulator globally.

By making this pledge, ArisGlobal is publicly confirming its commitment to uphold the highest standards and best practices related to AI governance, ethics, and responsibility. This will ensure that its life sciences clients can trust the benefits delivered by the technology, for instance in the form of new or honed patient safety insights.

ArisGlobal has signed the Pact as a demonstration of its commitment to customers of its LifeSphere Regulatory and Safety platform, powered by its advanced cognitive computing engine, NavaX.

By participating in the initiative, ArisGlobal is committing to:

  • AI governance strategy to foster the uptake of AI in the organization and work towards future compliance with the AI Act;
  • High-risk AI systems mapping: identifying AI systems likely to be categorized as high-risk under the AI Act; and
  • Promoting AI literacy and awareness among staff, ensuring ethical and responsible AI development.

Jason Bryant, ArisGlobal’s Vice President of Product Management for AI & Data, said, “At ArisGlobal, we believe that AI should benefit society, which isn’t possible without ethical AI practices. We take responsible AI very seriously. That is both via our leadership position in the industry, and as we apply the technology to deliver advanced insight – allowing our customers to make better decisions that feed into patient safety. Joining the AI Pact reinforces our commitment, and our belief in a future underpinned by responsible AI.”

He added, “Our progress will be as visible as our commitment. We will report on our performance against our core promises, as well as additional approaches we’ll be taking to drive best-of-breed industry behavior.”

About ArisGlobal

ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan, and China. For more updates, follow ArisGlobal on LinkedIn or visit arisglobal.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/arisglobal-signs-eu-ai-pact-in-latest-commitment-to-ethical-ai-practices-essential-for-societal-benefits-including-enhanced-patient-safety-302374651.html

SOURCE ArisGlobal

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

23 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

23 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

23 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

23 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

23 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

23 hours ago